Neovasc wins CE Mark for Peripatch aegis staple line product
This approval enables the company to begin marketing aegis products for sale in the EU. Peripatch aegis is a buttressing material designed to reinforce the staple line and
Akeso has received approval from China’s National Medical Products Administration (NMPA) for gumokimab (AK111), an anti-Interleukin-17 (IL-17) monoclonal antibody, to treat adults with moderate-to-severe plaque psoriasis.